ORIGINAL RESEARCH article
Front. Mater.
Sec. Biomaterials and Bio-Inspired Materials
Volume 12 - 2025 | doi: 10.3389/fmats.2025.1550323
This article is part of the Research TopicMultifunctional nanomaterials: Stand in the Center of Cancer Therapy as well as Tissue Regeneration and RepairView all 5 articles
Evaluation of multimodal imaging guided multifunctional bio-targeted reactive oxygen species production synergists: a preliminary study
Provisionally accepted- 1Chongqing General Hospital ,Chongqing University, State Key Laboratory of Ultrasound in Medicine and Engineering, Chongqing Medical University, Chongqing, China
- 2State Key Laboratory of Ultrasound in Medicine and Engineering, Chongqing Medical University, Chongqing, China
- 3Chongqing General Hospital, Chongqing University, State Key Laboratory of Ultrasound in Medicine and Engineering, Chongqing Medical University, Chongqing, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Pulse focused ultrasound (PFUS) is a novel non-invasive technique with reduced risk of thermal damage to normal tissue surrounding. As a result of the rapid attenuation of ultrasonic energy, synergists are critical to therapy process. However, due to various factors and the complex microenvironment in the tumor, synergists existed have limitations such as poor targeting, incomplete imaging during therapy, and tumor residue after therapy. Given that, the study aims to construct bio-targeted reactive oxygen species (ROS)-producing synergists consisting of Bifidobacterium bifidum (B. bifidum) that actively homing to the tumor and multifunctional ROS producing nanoparticles loaded with chlorin e6(Ce6) and perfuorohexane (PFH). The synergists are expected to achieve targeted and synergistic PFUS ablation, as well as multimodal imaging to guide diagnosis and therapy. The Ce6 carried in it is precisely released during PFUS and produces ROS, realizing PFUS combined with sonodynamic therapy(SDT) anti-tumor treatment. The strategy is expected to make up for the shortcomings of existing PFUS collaborative therapy, and provide an idea for tumor diagnosis and treatment.
Keywords: pFUS, bio-targeted, ROS, SDT, Multimodal Imaging
Received: 23 Dec 2024; Accepted: 21 Apr 2025.
Copyright: © 2025 xia, Yu, haiyan, Yan, zhong, li, qi and Jianzhong. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Yang haiyan, Chongqing General Hospital, Chongqing University, State Key Laboratory of Ultrasound in Medicine and Engineering, Chongqing Medical University, Chongqing, China
Zou Jianzhong, State Key Laboratory of Ultrasound in Medicine and Engineering, Chongqing Medical University, Chongqing, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.